Ignite Creation Date:
2025-12-25 @ 4:49 AM
Ignite Modification Date:
2025-12-26 @ 3:51 AM
Study NCT ID:
NCT05172518
Status:
NOT_YET_RECRUITING
Last Update Posted:
2021-12-29
First Post:
2021-12-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast Cancer
Sponsor:
Sun Yat-sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-27
First Submit QC Date:
None
Study First Post Date:
2021-12-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-27
Last Update Post Date:
2021-12-29
Last Update Post Date Type:
ACTUAL